The osteoporosis care gap in Canada

被引：61

作者：

Papaioannou A. ^{[1
,5
]}

Giangregorio L. ^{[2
,6
]}

Kvern B. ^{[3
,7
]}

Boulos P. ^{[1
,8
]}

Ioannidis G. ^{[4
,8
]}

Adachi J.D. ^{[1
,8
]}

机构：

[1] Department of Medicine, McMaster University, Hamilton, Ont.

[2] Department of Kinesiology, McMaster University, Hamilton, Ont.

[3] Department of Family Medicine, University of Manitoba, Winnipeg, Man.

[4] Charlton Medical Centre, Hamilton, Ont.

[5] Hamilton, Ont. L8N 1Y2

[6] AB111 IWC, Department of Kinesiology, McMaster University, Hamilton, Ont. L8S 4K1

[7] Winnipeg, Man. R2H 3E1

[8] Hamilton, Ont. L8N 1Y2

来源：

BMC Musculoskeletal Disorders | / 5卷 / 1期

关键词：

Canada; Diagnosis; Fracture; Osteoporosis; Treatment;

D O I：

10.1186/1471-2474-5-11

中图分类号：

学科分类号：

摘要：

Background: The presence of a fragility fracture is a major risk factor for osteoporosis, and should be an indicator for osteoporosis diagnosis and therapy. However, the extent to which patients who fracture are assessed and treated for osteoporosis is not clear. Methods: We performed a review of the literature to identify the practice patterns in the diagnosis and treatment of osteoporosis in adults over the age of 40 who experience a fragility fracture in Canada. Searches were performed in MEDLINE (1966 to January 2, 2003) and CINAHL (1982 to February 1, 2003) databases. Results: There is evidence of a care gap between the occurrence of a fragility fracture and the diagnosis and treatment of osteoporosis in Canada. The proportion of individuals with a fragility fracture who received an osteoporosis diagnostic test or physician diagnosis ranged from 1.7% to 50%. Therapies such as hormone replacement therapy, bisphosphonates or calcitonin were being prescribed to 5.2% to 37.5% of patients. Calcium and vitamin D supplement intake was variable, and ranged between 2.8% to 61.6% of patients. Conclusion: Many Canadians who experience fragility fracture are not receiving osteoporosis management for the prevention of future fractures.

引用

页数：18

共 29 条

[1]

Hellekson K.L., NIH releases statement on osteoporosis prevention, diagnosis, and therapy, Am Fam Physician, 66, pp. 161-162, (2002)

[2]

Papaioannou A., Watts N.B., Kendler D.L., Yuen C.K., Adachi J.D., Ferko N., Diagnosis and management of vertebral fractures in elderly adults, Am J Med, 113, pp. 220-228, (2002)

[3]

Davis J.W., Grove J.S., Wasnich R.D., Ross P.D., Spatial relationships between prevalent and incident spine fractures, Bone, 24, pp. 261-264, (1999)

[4]

Wasnich R.D., Davis J.W., Ross P.D., Spine fracture risk is predicted by non-spine fractures, Osteoporos Int, 4, pp. 1-5, (1994)

[5]

Brown J.P., Josse R.G., 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada, CMAJ, 167, (2002)

[6]

Castel H., Bonneh D.Y., Sherf M., Liel Y., Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures, Osteoporos Int, 12, pp. 559-564, (2001)

[7]

Freedman K.B., Kaplan F.S., Bilker W.B., Strom B.L., Lowe R.A., Treatment of osteoporosis: Are physicians missing an opportunity?, J Bone Joint Surg Am, 82 A, pp. 1063-1070, (2000)

[8]

Gardner M.J., Flik K.R., Mooar P., Lane J.M., Improvement in the undertreatment of osteoporosis following hip fracture, J Bone Joint Surg Am, 84 A, pp. 1342-1348, (2002)

[9]

Kiebzak G.M., Beinart G.A., Perser K., Ambrose C.G., Siff S.J., Heggeness M.H., Undertreatment of osteoporosis in men with hip fracture, Arch Intern Med, 162, pp. 2217-2222, (2002)

[10]

Onder G., Pedone C., Gambassi G., Landi F., Cesari M., Bernabei R., Treatment of osteoporosis among older adults discharged from hospital in Italy, Eur J Clin Pharmacol, 57, pp. 599-604, (2001)

← 1 2 3 →